CARL

17.2300.06%
KC

Kevin C. O’Boyle

Independent Director

Mr. Kevin C. O’Boyle is Independent Director of iRhythm Holdings, Inc. (formerly known as iRhythm Technologies, Inc.) from July 7, 2025. Mr. O’Boyle is Independent Director of Outset Medical, Inc. from May 14, 2025. Mr. O’Boyle served on the board of directors of Nevro Corp., a global medical device company, from March 2019 through April 2025 when the company was acquired by Globus Medical, Inc. He also served as Chairman of the board of directors of GenMark Diagnostics, Inc., a diagnostics company until its acquisition by Roche in May 2021. Additionally, Kevin also served on the boards of directors of Sientra, Inc., a medical aesthetics company, from May 2014 to June 2023, Wright Medical Group N.V. (acquired by Stryker), a global medical device company, from November 2015 to November 2020, Zeltiq Aesthetics, Inc. (acquired by Allergan), a medical aesthetics company, from July 2011 to April 2017 and Durata Therapeutics, Inc. (acquired by Actavis), a pharmaceutical company, from May 2012 to November 2014. He also currently serves on the board of directors of Carlsmed, a private company specializing in personalized spine surgery solutions. Previously, Kevin served as Senior Vice President and Chief Financial Officer of Advanced Biohealing Inc., a medical device company, from December 2010 until it was acquired in July 2011. Prior to that, he served as Chief Financial Officer of NuVasive, Inc., a medical device company, from January 2003 to December 2009. Earlier in his career, he served in various leadership positions during his six years with ChromaVision Medical Systems, Inc. Kevin holds a B.S. in Accounting from the Rochester Institute of Technology.

Positions